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ABSTRACT
Ribosome biogenesis is tightly linked to cellular
growth. A crucial step in the regulation of ribosomal
RNA (rRNA) gene transcription is the formation of
the complex between RNA polymerase I (Pol I) and
the Pol I-dependent transcription factor Rrn3p. We
found that TOR inactivation leads to proteasome-
dependent degradation of Rrn3p and a strong
reduction in initiation competent Pol I–Rrn3p
complexes affecting yeast rRNA gene transcription.
Using a mutant expressing non-degradable Rrn3p
or a strain in which defined endogenous Rrn3p
levels can be adjusted by the Tet-off system, we
can demonstrate that Rrn3p levels influence the
number of Pol I–Rrn3p complexes and consequently
rRNA gene transcription. However, our analysis
reveals that the dramatic reduction of rRNA synthe-
sis in the immediate cellular response to impaired
TOR signalling cannot be explained by the simple
down-regulation of Rrn3p and Pol I–Rrn3p levels.
INTRODUCTION
A crucial step in the regulation of ribosome synthesis is
the adjustment of ribosomal RNA (rRNA) gene
transcription according to changes in the extracellular
environment. Production of rRNAs depends on multiple
signalling pathways responding to nutrient availability,
stress stimuli or mitogen activation (1–3). One bona
ﬁde target of the intracellular signal transduction
pathways is the ribosomal gene transcription apparatus
including RNA Pol I and associated transcription
factors. Some of them like mammalian UBF, SL1 and
Rrn3/TIF-IA were shown to be either aﬀected by
mitotic silencing (4,5) or growth regulated by
MAP-kinase (6–8) the mTOR- (target of rapamycin)
(9–12), JNK- (13) and casein kinase II-pathways
(14–16). These studies suggested that site speciﬁc phos-
phorylation of single factors results in either enhanced
or reduced formation of Pol I-complexes initiating tran-
scription at the rDNA promoter. Furthermore,
rapamycin-dependent inactivation of rRNA synthesis
correlated with the dissociation of Rrn3p/TIF-IA from
Pol I and with its translocation from the nucleolus to
the cytoplasm (12). It was also proposed that UBF asso-
ciation with the transcribed rDNA region might act as an
obstacle for the elongating form of Pol I that can be
overcome by growth factor-dependent phosphorylation
(17). On the other hand, UBF was suggested to play a
role in promoter escape (18). Thus, it appears that eukary-
otic rDNA transcription can be regulated at many diﬀer-
ent levels.
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TOR function and several targets of TOR signalling af-
fecting the Pol I-machinery were proposed, TOR controls
ribosome biogenesis also by stimulating transcription of
ribosomal protein genes (19–21) and mRNA translation,
the latter especially through translation initiation factor
4E-binding proteins and through the S6 kinase (S6K)
[see as review (22)]. Whether and how TOR controls
these diﬀerent processes in a coordinated manner is not
understood.
In Saccharomyces cerevisiae, formation of initiation
complexes at the 35S ribosomal DNA (hereafter called
rDNA, rRNA gene) promoter depends on the cooperate
activity of upstream activating factor (UAF) with
TATA-binding protein, core factor (CF) and initiation
competent Pol I which is tightly associated with Rrn3p
[reviewed in (3,23)]. Availability of the Pol I–Rrn3p
complex represents a limiting step to support 35S rRNA
gene transcription. In cells grown to stationary phase or
treated with rapamycin, which impairs TOR signalling,
the amounts of Pol I–Rrn3p complexes were signiﬁcantly
reduced (11,24). In these conditions Rrn3p-dependent re-
cruitment of Pol I to the rDNA promoter is impaired (11).
Concordantly, in yeast cells expressing a covalently
bound, non-dissociable complex between Rrn3p and Pol
I, down-regulation of rDNA transcription is delayed and
Pol I occupancy at the rDNA promoter remains high after
inactivation of the TOR pathway (25).
We investigated how nutrient deprivation aﬀects rDNA
transcription in yeast and found that Rrn3p-levels are
rapidly reduced upon TOR inactivation whereas Pol
I-levels remain unaﬀected. Rrn3p is constitutively
degraded by the proteasome and Rrn3p levels decrease
as soon as synthesis of the protein is derogated. We
found that degradation of Rrn3p correlates with the loss
of Pol I–Rrn3p complexes and a reduced Pol I occupancy
at the 35S rDNA promoter and coding region. To analyse
if Rrn3p degradation plays a major role in the
down-regulation of rRNA gene transcription in starved
cells, we analysed mutant strains in which Rrn3p
levels are unaﬀected upon TOR inactivation. We found
that in these cells Pol I–Rrn3p complex formation and
Pol I recruitment to rDNA is only marginally impaired
by TOR inactivation while growth inhibition and
shut-down of the synthesis of mature rRNAs cannot be
rescued. By using the Tet-oﬀ system to adjust deﬁned
Rrn3p levels we demonstrate that decreasing the amount
of cellular Rrn3p results in reduced rDNA transcription
and growth rate. However, even minimal amounts of
Rrn3p support rRNA production and cell growth. We
conclude that the almost complete inhibition of
ribosome synthesis upon TOR inactivation cannot fully
be explained by Rrn3p degradation and thus reduced
rDNA transcription initiation.
MATERIALS AND METHODS
Yeast strains, plasmids and media
See Supplementary Data.
Preparation of yeast whole cell extracts
Yeast cells were harvested by centrifugation (3min, 3000g,
4 C) and washed once with cold H2OMillipore. After sus-
pending the pellets in the same volume of cold lysis buﬀer
[20% (w/v) glycerol, 150mM HEPES (pH 7.6), 10mM
MgCl2, 400mM (NH4)2SO4,5 m Mb-mercaptoethanol,
1mM PMSF, 2mM benzamidine], cells were broken for
45min with pre-cooled glass beads (Ø 0.75–1.0mm, Roth)
on a VXR basic Vibrax (IKA) with 2000–2200r.p.m. at
4 C. The suspensions were mixed with 150–250ml of cold
lysis buﬀer and glass beads and cell debris were sedi-
mented (15min, 13000r.p.m., 4 C). The supernatants
[whole cell extracts (WCEs)] were frozen in liquid
nitrogen and stored at  80 C.
Isolation of (poly)ubiquitylated proteins from
yeast extracts
WCEs were adjusted to 750mM KOAc, 0.5% (v/v)
Nonidet P40, 0.05% (v/v) Triton X-100 and incubated
with recombinant GST-Dsk2p bound to 50ml glutathione
sepharose (GE Healthcare). Dsk2p is an ubiquitin-binding
protein. A mock isolation using recombinant GST bound
to 50ml glutathione sepharose (GE Healthcare) served as a
control. After batch binding beads were washed twice with
750mM KOAc, 0.5% Nonidet P40 and twice with PBS.
Precipitated proteins were eluted from the beads with SDS
sample buﬀer and analysed by western blotting.
In vivo pulse labelling and northern blot experiments
After harvesting 3–5ml of yeast cultures, cells were sus-
pended in 1ml of the respective medium and
pulse-labelled for 15min with 20mCi [5,6-
3H] uracil
(Amersham) at 30 C. Total RNA was isolated by
hot-phenol extraction and ethanol-sodium acetate precipi-
tation (26), separated in a denaturing 1.3% agarose gel
and transferred onto a nylon membrane (Positive
TM,
Qbiogene).
3H-labelled rRNAs were visualized using a
BAS-MS 2040 imaging plate (Fujiﬁlm) and a BAS 1000
phosphorimager (Fujiﬁlm, 4–5days exposition).
Quantiﬁcation was performed using the Image Gauge
software (Fujiﬁlm).
For northern blot analysis membranes were hybridized
with a
32P-labelled 25S oligonucleotide probe (#212:
50-CTC CGC TTA TTG ATA TGC-30) using the
RadPrime DNA labelling system (Invitrogen) with incorp-
oration of [a-32P]dATP (Hartmann analytic) according to
the instructions of the manufacturer. Quantiﬁcation was
performed as described above, but using a BAS-III
imaging plate (Fujiﬁlm).
Gelﬁltration of yeast WCEs
Yeast WCEs were ﬁrst clariﬁed by centrifugation (40min,
100000g,4  C). The supernatants (900mg of protein)
were loaded on a Superose 6HR10/30 column
(FPLC, Pharmacia Biotech) and separated in a high
salt buﬀer [10% (w/v) glycerol, 20mM HEPES (pH 7.8),
2mM MgCl2, 0.02mM EDTA, 1.5M potassium
acetate, 0.05% (v/v) Tween 20, 5mM b-mercaptoethanol,
1mM PMSF, 2mM benzamidine] at a ﬂow rate of
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amount of 250ml of every second fraction were TCA
precipitated and analysed by western blotting.
Co-immunoprecipitations
To characterize the Pol I–Rrn3p interaction in yeast
strains pNOP1-RRN3-Prot.A-RPA43-HA3 and pNOP1-
RRN3-N-Prot.A-RPA43-HA3, cells were crosslinked
and lysed as described [(27) and below]. The HA3-tagged
Pol I subunit A43 was immunoprecipitated from 250mlo f
the resulting extracts with 1.5mg of an anti-HA antibody
(3F10, Roche) bound to 50ml of Protein G sepharose
(Amersham). For the following washing steps the chroma-
tin IP washing buﬀers were used (see below). To elute the
immunoprecipitated proteins and to reverse the crosslink,
the beads were mixed with SDS sample buﬀer and
incubated for 20min at 95 C. Fifty percent of the
eluates were analysed by western blotting.
To determine the amounts of co-precipitated Rrn3p,
both the Rrn3p and the A43 signals were detected with
the LAS 3000 imaging system and quantiﬁed using the
AIDA software (Raytest). Then, the Rrn3p levels were
normalized to the A43 levels and the values of the
growth arrested cells were related to the values obtained
with extracts of growing cells which were put arbitrarily to
100%.
Chromatin immunoprecipitations
Chromatin immunoprecipitations were performed as
described (27). An amount of 45ml yeast cultures
(OD600=1.0) were crosslinked for 15 or 30min with
1% (v/v) formaldehyde at 30 C. The cells were harvested
by centrifugation and suspended in the same volume of
cold lysis buﬀer [50mM HEPES (pH 7.5), 140mM NaCl,
1mM EDTA, 1% (v/v) Triton X-100, 0.1% (w/v) DOC,
1mM PMSF, 2mM benzamidine]. Glass beads (Ø 0.75–
1.0mm, Roth) were added and cells were disrupted on a
VXR basic Vibrax (IKA) for 45min with 2000–
2200r.p.m. at 4 C. After discarding the glass beads, the
lysates were soniﬁed to obtain an average DNA fragment
size of 500–1000bp. Cell debris was removed from the
lysates by centrifugation (20min, 13000r.p.m., 4 C).
The resulting chromatin extracts were incubated for 2h
at 4 C with 1.5mg of a monoclonal a-HA antibody (3F10,
Roche) bound to 50ml of Protein G sepharose
(Amersham) to enrich the HA3-tagged Pol I subunit
A43. After immunoprecipitation, the beads were washed
three times with lysis buﬀer (without protease inhibitors),
twice with washing buﬀer I [50mM HEPES (pH 7.5),
500mM NaCl, 1mM EDTA, 1% (v/v) Triton X-100,
0.1% (w/v) DOC] and twice with washing buﬀer II
[10mM Tris–HCl (pH 8.0), 250mM LiCl, 1mM EDTA,
0.5% (v/v) Nonidet P40, 0,5% (w/v) DOC] followed
by a ﬁnal washing step with TE buﬀer [10mM Tris–HCl
(pH 8.0), 1mM EDTA]. Immunoprecipitated material
was eluted from the beads by incubating the samples for
10min at 65 C in the presence of 140ml of buﬀer TE con-
taining 1% (w/v) SDS. To reverse the crosslink, 120mlo f
the eluates (IPs) as well as 40ml of the chromatin extracts
mixed with 80ml of TE buﬀer containing 1% SDS (inputs)
were heated over night at 65 C. Then, proteins were
digested by mixing the samples with 130ml of TE buﬀer
containing 1.54mg/ml Proteinase K (Sigma). After 2h of
incubation at 37 C, DNA was isolated by phenol–chloro-
form extraction and ethanol-LiCl precipitation. Both, the
input and the IP DNA were suspended in 50mlo fT E
buﬀer.
DNA dilutions of 1: 2000 (inputs) and 1: 400 (IPs) were
analysed in triplicates by quantitative real-time PCR using
a RotorGene RG-3000 system (Corbett Research) and the
SYBR Green I dye (Roche) for detection. To characterize
the rDNA occupancy of Pol I subunit A43, a rDNA
promoter fragment, a part of the 18S and 25S rRNA
coding region and a 5S rRNA gene fragment were
ampliﬁed using the following oligonucleotides: #969
(50-TCA TGG AGT ACA AGT GTG AGG A-30) and
#970 (50-TAA CGA ACG ACA AGC CTA CTC-30),
#710 (50-TGG AGC AAA GAA ATC ACC GC-30)
and #711 (50-CCG CTG GAT TAT GGC TGA AC-30),
#712 (50-GAG TCC TTG TGG CTC TGG GC-30) and
#713 (50-AAT ACT GAT GCC CCC GAC C-30), #920
(50-GCC ATA TCT ACC AGA AAG CAC C-30) and
#921 (50-GAT TGC AGC ACC TGA GTT TCG-30).
Data were evaluated using the comparative quantitation
module of the RotorGene analysis software (version 6.1,
Corbett Research) and the MS Oﬃce program Excel 2003.
After normalizing the IP to the respective input values,
relative occupancies were obtained by relating data to
the promoter occupancy of the growing cells, which was
put arbitrarily to 1.0.
Fractionation
Nuclear and cytoplasmic fractions were prepared as
described (28) according to the method of (29) with the
modiﬁcation that 12ml of yeast cultures were grown to an
OD of 0.8 before they were harvested.
Psoralen crosslinking analyses
Psoralen crosslinking was carried out as previously
described (30).
Southern blot analysis
Blot analysis and quantitation have been performed as
described elsewhere (30). Templates for probe prepar-
ation, detecting the rDNA locus were an Eco RI
fragment spanning nt 323–2277 of the 35S rDNA, and
a 3.5kb Nco I-fragment spanning nt 1045–4491 of the
35S rDNA.
Immunolocalization
Immunoﬂuorescence microscopy was performed accord-
ing (28).
Specimen preparation for electron microscopy
Yeast chromatin spreading was performed as described
in (31).
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Reduction of Rrn3p-levels in growth-arrested yeast cells is
dependent on the proteasome
We have previously reported that down-regulation of
rRNA synthesis in stationary yeast cells coincides with a
lower recovery of Pol I–Rrn3p complexes (24). A clear
reduction of Pol I–Rrn3p complexes was also observed
by us (data not shown) and others when pre-rRNA syn-
thesis was down-regulated by the protein synthesis inhibi-
tor cycloheximide, by nutrient starvation, or rapamycin,
an inhibitor of TOR-kinases which mimics conditions of
nutrient starvation (32) (11,12,33,34).
This reduction of Pol I–Rrn3p complexes in yeast cor-
relates with decreasing amounts of Rrn3p in whole cell
extracts. When exponentially growing yeast strains were
either treated with cycloheximide or rapamycin, or
depleted in an essential amino acid, Rrn3p levels were
rapidly reduced (Figure 1A). After 120min, Rrn3p-levels
dropped below 20% of the initial amount in all three
conditions. A reduced level of Rrn3p is also detectable if
Pol II-dependent transcription is inhibited i.e. when a
temperature-sensitive RNA polymerase II mutant
(rpb1-1) is shifted to the restrictive temperature, or if
cells are in stationary phase (data not shown). In
contrast, Pol I levels remain rather stable in growth
arrested cells (Figure 1A, lower panel, data not shown).
This demonstrates that inactivation of both, TOR
pathway, and protein synthesis results in a reduction of
the Rrn3p protein level.
The rapid down-regulation of Rrn3p in growth ar-
rested cells depends on the proteolytic activity of the pro-
teasome. In a temperature-sensitive mutant which is
defective in CIM3/SUG1, a gene coding for an essential
subunit of the regulatory 19S subunit of the proteasome
(35,36), Rrn3p is stable upon amino-acid depletion at
the restrictive temperature (Figure 1B). In contrast,
deletion of vacuolar proteases like PEP4 does not aﬀect
the reduction in Rrn3p levels after growth arrest (data not
shown).
Figure 1. Rrn3p levels are reduced upon TOR inactivation and proteasome-dependent degradation. (A) Rrn3p is degraded upon TOR inactivation
and inhibition of translation. Yeast strain RRN3-Prot.A expressing a chromosomally Prot.A-tagged Rrn3p was grown in YPD at 30 C to mid-log
phase (OD600&0.4; t=0min), before the cells were either treated with 200ng/ml of rapamycin or with 100mg/ml of cycloheximide, or starved in
SDC-Leu (aa-depletion), respectively. At the time points indicated cells were collected and lysed. Same amounts of WCE (20mg) were analysed by
western blotting using antibodies directed against the Prot.A-tag of Rrn3p and the Pol I speciﬁc subunit A43, respectively. (B) Rrn3p-degradation
depends on proteasome activity. The proteasome ts-mutant strain (cim3-1, TOY 652) expressing a chromosomally TAP-tagged Rrn3p or the isogenic
CIM3 WT strain (WT, TOY 651) were grown to mid-log phase in YPD at 24 C( t=0min), before the cells were starved at 37 C in SDC-Leu
medium (-Leu). At the time points indicated cells were collected and lysed. Same amounts of WCE (30mg) were analysed by western blotting using
antibodies directed against the TAP-tag of Rrn3p and the Pol I subunit A135, respectively. (C) Rrn3p is ubiquitylated. Yeast strain
pNOP1-RRN3-Prot.A, expressing Prot.A-tagged Rrn3p from a plasmid was grown in YPD at 30 C to midlog phase, before half of the cells
were treated with 200ng/ml of rapamycin for 10min. Cells of rapamycin treated and untreated cultures were collected and lysed. Same amounts
of WCEs (6mg) were incubated with either recombinant GST-Dsk2p, or recombinant GST immobilized on 50ml of glutathione sepharose. After
washing, proteins bound to the beads were eluted with SDS sample buﬀer. Same amounts (1%) (50mg) of input (IN) and ﬂow through (FT), 0.5% of
the wash steps (washes) and 50% of the eluate (E) were analysed by western blotting using antibodies directed against the Prot.A-tag of Rrn3p.
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degraded if protein neosynthesis is blocked
To investigate whether Rrn3p-degradation is induced
by ubiquitylation we compared ubiquitylation of
Rrn3p-Prot.A (WT) before and after inhibition of the
TOR pathway. It was previously reported that
ubiquitylated proteins can be speciﬁcally enriched by
their aﬃnity to the immobilized (poly) ubiquitin-binding
protein Dsk2p (37). We generated whole-cell extracts from
yeast strains expressing Rrn3p-Prot.A before and after
10min of rapamycin treatment. Rrn3p-Prot.A-containing
extracts were incubated with GST (Figure 1C, lanes 1–7)
or GST-Dsk2p (Figure 1C, lanes 8–14) fusion protein
immobilized on glutathione sepharose. After washings,
the GST-baits and associated proteins were eluted and
subjected to western blot analysis. Rrn3p-Prot.A was
selectively retained by GST-Dsk2p, but not GST alone
(Figure 1C and Supplementary Figure S1A, central
panel). We also observe speciﬁc retention of (poly)ubiqui-
tin and (poly)ubiquitinated proteins on the GST-Dsk2p
beads (Supplementary Figure S1A, lower panel). In
contrast, binding of the Pol I subunit A135 to immobilized
GST-DSK2p in such an experiment was at background
level. (Supplementary Figure S1A, upper panel).
Rrn3p-Prot.A co-eluting with GST-Dsk2p migrated with
slightly lower mobility in SDS–PAGE than Rrn3p-Prot.A
in the input and ﬂow-through fractions (Figure 1C,
compare lanes 14 with lanes 8 and 9). Even larger
Rrn3p-TAP species, likely representing polyubiquitylated
Rrn3p-TAP, could be bound to immobilized GST-Dsk2p
from extracts of cells expressing the proteasome deﬁcient
cim3-1 mutant and cultured at the restrictive temperature
(Supplementary Figure S1B). Interestingly, neither the
amount of ubiquitylated Rrn3p-Prot.A bound by Dsk2p
nor the extent of polyubiquitylation did increase upon
rapamycin treatment (Figure 1C and Supplementary
Figure S1B). This suggests that Rrn3p ubiquitylation
and proteasome-dependent degradation are not induced
upon TOR inactivation. In fact, we observe a strong
decrease in RRN3 mRNA levels after 20min of
rapamycin treatment (Supplementary Figure S1C). This
is in good agreement with previous transcriptome
analyses (38). Thus, the observed decrease of the Rrn3p
level is rather due to the inhibition of RRN3 expression
and the rapid turnover of the protein.
A C-terminal Prot.A-tagged Rrn3p lacking the 17
N-terminal amino acids is stable upon nutrient starvation
We found a remarkably increased Rrn3p stability in con-
ditions in which TOR is inactive in a strain expressing a
C-terminally Prot.A-tagged Rrn3p mutant containing a
truncation of the 17 N-terminal amino acids (N)
(Figure 2). Deletion of the N-terminal 17 amino acids is
required, but not suﬃcient to inhibit Rrn3p-degradation
(data not shown). The C-terminal Prot.A-tag also contrib-
utes to Rrn3p-N-Prot.A stability, and accordingly
Rrn3p-Prot.A fusion proteins show an increased stability
compared to Rrn3p-HA (data not shown). The
plasmid-encoded N-mutant fully rescues growth in an
rrn3 deletion strain (Figure 2B). Rrn3p-N-Prot.A levels
remained stable even after 2h of amino acid depletion
whereas in this condition about 80% of Rrn3p were
degraded in the corresponding reference strain expressing
plasmid encoded wild-type Rrn3p-Prot.A (Figure 2C). In
our following studies, this mutant served as a tool to in-
vestigate how the stability of Rrn3p inﬂuences the integ-
rity of the transcription machinery and the synthesis of
rRNA in response to nutrient starvation.
Non-degraded yeast Rrn3p keeps its subcellular
localization in growth-arrested cells
It has previously been reported that upon TOR-
inactivation mammalian Rrn3p/TIFIA translocates from
the nucleolus to the cytoplasm (12). Therefore, we
Figure 2. N-terminally truncated Rrn3p-Prot.A (Rrn3p-N-Prot.A) is stable upon TOR inactivation. (A) Primary structure of the wild-type protein
Rrn3p-Prot.A and the N-terminally truncated version Rrn3p-N-Prot.A. The 16 amino acids deleted in Rrn3p-N-Prot.A are indicated in red. The
two fusion proteins are expressed from a centromeric vector under the control of the NOP1 promoter in a strain deleted in the endogenous RRN3
locus. (B) Growth curves of strains pNOP1-RRN3-Prot.A (WT) and pNOP1-RRN3-N-Prot.A (N) cultured at 30 C in YPD. (C)
Rrn3p-N-Prot.A resists degradation. Yeast strains pNOP1-RRN3-Prot.A (WT) and pNOP1-RRN3-N-Prot.A (N) were grown in YPD at
30 C to mid-log phase (t=0min) and then starved in SDC-Trp (-Trp). At the time points indicated cells were collected and lysed. Same
amounts of WCE (30mg) were analysed by western blotting using antibodies directed against the Prot.A-tag of the Rrn3p versions and the Pol I
subunit A135, respectively.
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after nutrient deprivation occurs also in yeast.
Immunolocalization experiments conﬁrmed that Rrn3p
disappears rapidly after nutrient starvation in wild-type
cells, but neither in the N-mutant (Figure 3A), nor
in proteasome-deﬁcient cim3-1 cells (Figure 3B).
Furthermore, in both mutants the nuclear-cytoplasmic
distribution of Rrn3p did not change. The amount of
cytoplasmic versus nuclear Rrn3p-N-ProtA was also
analysed by western blotting after fractionation of
whole cells into nuclei and cytoplasm (Supplementary
Figure S2). In accordance with the immunolocalization
experiments the ratio between nuclear and cytoplasmic
Rrn3p was very similar before and after depletion. From
these experiments we conclude that the major population
of wild-type yeast Rrn3p does not translocate after
nutrient depletion.
Maintaining Rrn3p levels upon nutrient depletion preserves
the number of Pol I–Rrn3p complexes
We asked how nutrient availability inﬂuences formation
of Pol I–Rrn3p complexes in wild-type and mutant strains.
Many experiments of several groups including ours
demonstrated that down-regulation of rDNA transcrip-
tion correlates with the dissociation of the Pol I–Rrn3p
complex in stationary and growth-arrested cells. We have
previously reported that Rrn3p is present in three diﬀerent
forms in whole cell extracts of exponentially growing cells
(39). The major Rrn3p fraction is monomeric, about 20%
are tightly bound to Pol I, whereas the remaining Rrn3p
is associated with a high molecular weight complex.
To distinguish between the three forms of Rrn3p we per-
formed gelﬁltration experiments with whole cell extracts
derived from the Rrn3p-Prot.A wild-type and N mutant
strain before and after amino-acid depletion (Figure 4A).
In nutrient depleted wild-type cells, Rrn3p is signiﬁcantly
reduced to a similar extent in all three populations
(Figure 4A, panels WT). In contrast, in the N-mutant
the amounts of Rrn3p in all fractions before and after nu-
trient depletion are comparable (Figure 4A, panels N),
suggesting that in this genetic background Pol I–Rrn3p
complexes persist upon growth arrest. Similarly, in the
cim3-1 mutant strain both, the total amount of Rrn3p
and the ratio of complexed versus free Rrn3p did not
change signiﬁcantly before and after nutrient depletion
(Supplementary Figure S3A, panels cim3-1). These
results indicate that maintaining Rrn3p levels upon
nutrient depletion preserves the number of Pol I–Rrn3p
complexes.
To assess the number of Pol I–Rrn3p complexes in
the two diﬀerent genetic backgrounds more quantitatively,
co-immunoprecipitation experiments under stringent
conditions were performed before and after nutrient
depletion (Figure 4B). In extracts from nutrient depleted
wild-type cells the amount of Rrn3p-Prot.A
co-precipitating with HA-tagged Pol I-subunit A43
is strongly reduced, when compared to co-
immunoprecipitation experiments with extracts from
cells before nutrient depletion (Figure 4B, compare lane
7 with lane 8). In contrast, when the same experiments
were carried out with extracts from the N-strain in
which Rrn3p levels are maintained after nutrient deple-
tion, N-Rrn3p-Prot.A association with Pol I was
Figure 3. The subcellular distribution of stabilized yeast Rrn3p does not change upon nutrient starvation. (A) Immunolocalization.
pNOP1-RRN3-Prot.A (WT) and pNOP1-RRN3-N-Prot.A (N) cells either logarithmically growing or after amino-acid depletion were ﬁxed
with 4% paraformaldehyde and treated with zymolyase to generate spheroplasts. Anti-protein A antibodies and an Alexa 594-conjugated secondary
antibody were used to detect the Prot.A-tagged Rrn3p versions (in red), whereas the DNA was stained with DAPI (in blue). (B) Rrn3p-TAP does not
change its subcellular localization if proteasome-dependent degradation is inhibited. The proteasome ts-mutant cim3-1 (TOY 652)(with
chromosomally TAP-tagged Rrn3p) and the isogenic WT strain (TOY 651) were grown at 24 C in YPD medium to mid-log phase, before the
cells were starved at 37 C in SDC-Leu medium. After 2h the cells were ﬁxed with 4% paraformaldehyde and treated with zymolyase to generate
spheroplasts. TAP-tagged Rrn3p was detected with an a-protein A primary antibody and an Alexa 594-conjugated secondary antibody (in red), while
the DNA was stained with DAPI (in blue).
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compare lanes 9 and 10 with lanes 7 and 8). This result
indicates that in nutrient-depleted wild-type cells endogen-
ous Rrn3p-levels and (as a consequence) the number of
Rrn3p–Pol I complexes are reduced. On the other hand,
some reduction of Rrn3p–Pol I complexes is also observed
if TOR is inhibited in the N-mutant. In the experiment
depicted in Figure 4B, 64% N-Rrn3p-Prot.A remained
bound to Pol I (Figure 4B, lanes 9 and 10), although the
Rrn3p levels are very similar before and after nutrient
starvation (Figure 4B, lanes 3 and 4). Similar results
were obtained when Rrn3p–Pol I complexes were
analysed by co-immunoprecipitation in the cim3-1
mutant (Supplementary Figure S3B). Accordingly, the re-
duction of endogenous Rrn3p levels is one important
cellular process to decrease the amount of Pol I–Rrn3p
complexes, but there are additional mechanisms, which
contribute.
Figure 4. Stabilization of cellular Rrn3p levels attenuates the reduction in initiation competent Pol I–Rrn3p complexes observed upon nutrient
depletion. (A) Gelﬁltration analysis. Yeast strains pNOP1-RRN3-Prot.A (WT) and pNOP1-RRN3-N-Prot.A (N) were grown in YPD at 30 Ct o
mid-log phase. Cells were either starved for 2h in SDC-Trp (-Trp) or further cultured in YPD and collected by centrifugation. After lysis, same
amounts of WCE (900mg) were separated on a Superose-6 column in a buﬀer containing 1.5M potassium acetate. An amount of 250ml of the
collected 500ml fractions were TCA precipitated and analysed by western blotting together with the ‘Load’ (30mg). Antibodies used were directed
against the Prot.A-tag of the Rrn3p versions and the Pol I subunit A135, respectively. The gel ﬁltration fractions containing the initiation competent
Pol I–Rrn3p complexes are labelled in red. (B) Co-immunoprecipitations. Yeast strains TOY 684 (WT) and TOY 685 (N), both expressing
chromosomally HA3-tagged Pol I subunit A43 and either full length or truncated Prot.A-tagged Rrn3p, were grown in YPD at 30 C to mid-log
phase and half of the cells was crosslinked with 1% formaldehyde, harvested and lysed (t=0min). The remainder of the cells was starved in
SDC-Trp (-Trp) for 2h and treated as described above (t=120min). The HA3-tagged Pol I subunit A43 was immunoprecipitated (a-HA-IPs) from
250ml of extracts (Inputs) with anti-HA antibody. Fifty percent of the a-HA-IPs as well as 1% of the inputs were analysed by western blotting using
antibodies directed against the Prot.A-tag of the Rrn3p versions and the HA-tag of the Pol I subunit, respectively. As a control an identical
co-immunoprecipitation experiment was performed using extracts from yeast strain pNOP1-RRN3-Prot.A and pNOP1-Rrn3-N-Prot.A, which do
not express the HA-tagged Pol I subunit A43 (ctr.). Western blot signal intensities were measured, and quantiﬁed using the LAS 3000 imaging system
and the AIDA software. Rrn3p/A43 ratios were calculated, and the ratio of the 120min samples was normalized to the ratio of the respective 0min
samples which was set to 100%. Numbers calculated are given below each lane. (C) Chromatin-IP (ChIP) experiments. Yeast strains
pNOP1-RRN3-Prot.A (WT) and pNOP1-RRN3-N-Prot.A (N), both expressing either chromosomally HA3-tagged Pol I subunit A43 or the
core-factor subunit Rrn6p, were grown in YPD at 30 C to mid-log phase and half of the cells was crosslinked with 1% formaldehyde, harvested,
lysed and soniﬁed. The remainder of the cells was starved in SDC-Trp for 2h and treated as described above (-TRP). Rrn3p-Prot.A, the HA3-tagged
Pol I subunit A43 or Rrn6p were immunoprecipitated from the chromatin extracts. After DNA isolation the relative amounts of speciﬁc DNA
fragments co-purifying with the proteins were measured in triplicate real-time PCR reactions using primers speciﬁc for the rDNA promoter (P) and
the 25S rRNA coding region (25S) as well as for the 5S rRNA gene (5S) which served as an internal control. Data were normalized to the promoter
occupancy in growing wild-type cells and represent the mean of at least three independent ChIP experiments. (D) Reduction of 35S pre-rRNA
synthesis is attenuated in the N-mutant after TOR inactivation. (Upper panel) Yeast strains pNOP1-RRN3-Prot.A (WT) and
pNOP1-RRN3-N-Prot.A (N) were cultured to mid-log phase (t=0min), before the cells were treated with 200ng/ml of rapamycin. At the
time points indicated 5ml of the cultures were pulse labelled for 15min with 20mCi of [5, 6-
3H] uracil, and total RNA was isolated. Equal amounts
of total RNA were separated in a denaturing agarose gel and blotted onto a nylon membrane.
3H-labelled RNAs were visualized and quantiﬁed
using the BAS 1000 imaging system and the Image Gauge software. To determine the total RNA load per lane the membrane was hybridized with a
32P-labelled oligonucleotide probe directed against the mature 25S rRNA (northern blot). Radioactive signals were visualized and quantiﬁed as
described above. (Lower panel) The ratio of nascent 35S precursor rRNA to total 25S rRNA in the diﬀerent rapamycin treated samples was
determined and normalized to the 35S rRNA to 25S rRNA ratio of the untreated sample, which was arbitrarily set to 100.
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attenuates the decrease of Rrn3p and Pol I association
with rRNA genes and the shut down of transcription
upon nutrient depletion
To investigate whether stable levels of Pol I–Rrn3p
complexes in the N-mutant correlate with robust recruit-
ment of Pol I to the rDNA even after inactivation of the
TOR pathway, we performed ChIP (chromatin
immunoprecipitation) experiments. In good agreement
with previous results where TOR signalling was inhibited
by the addition of rapamycin (11,40), we observe a
decrease of Pol I promoter DNA and DNA fragments
of the 35S rRNA coding sequence co-precipitating with
Pol I in extracts from wild-type cells being starved of es-
sential amino acids to about 40% of the co-precipitation
before starvation (Figure 4C, central panel). The same was
observed for Pol I promoter DNA co-purifying with
Rrn3p (Figure 4C, left panel). In contrast, in extracts of
the N-mutant co-precipitation of the respective rDNA
fragments with either Rrn3p or Pol I decreased only to
about 60% upon starvation (Figure 4C). Accordingly, the
reduction in endogenous Rrn3p levels when nutrients
become limiting signiﬁcantly contributes to but does not
fully explain the decreased Pol I loading on rRNA genes in
this situation. Nutrient depletion did not lead to signiﬁ-
cant changes in the association of promoter bound
subunits of the transcription factor CF (Figure 4C, right
panel) and UAF [data not shown, see also (11)] in
wild-type cells and the N-mutant. Thus, CF and UAF
remain stably associated with the rDNA promoter upon
TOR inactivation although the formation and recruitment
of the Pol I–Rrn3p complex is impaired.
Interestingly, the absolute amount of rDNA
co-precipitating with Pol I, Rrn3p and CF was modestly
increased in the N-mutant. Since only half out of the 150
rRNA genes of the yeast rDNA locus are actively
transcribed in wild-type conditions, this could mean that
this number is slightly enhanced in strains carrying the
mutant rrn3 allele. Electronmicroscopic inspection of
rRNA genes by the Miller chromatin spreading method
(41,42) suggested a higher density of actively transcribed
rDNA genes in individual nucleolar regions released from
N-mutant cells when compared to nucleolar regions
released from wild-type cells (Supplementary Figure
S4A). To validate the impression obtained in these
single-cell analyses, we turned to psoralen crosslinking ex-
periments in which actively transcribed and transcription-
al inactive rRNA genes can be distinguished and are
averaged over a large cell population (30,43,44). We
observed a slight increase (<15%) in the number of
actively transcribed rRNA genes in the N-mutant in
direct comparison with the corresponding wild-type
strain (Supplementary Figure S4B) providing a possible
explanation for the increased amount of 35S rRNA gene
segments co-precipitating with Rrn3p and Pol I in the
mutant strain compared to the corresponding wild-type
strain in the above ChIP experiments (Figure 4C).
To investigate how stabilization of Rrn3p levels upon
TOR inactivation inﬂuences rRNA-production we
examined new synthesis of the primary rRNA transcript
in the wild-type strain and the N-mutant. We performed
pulse labelling experiments with
3H uracil and found that
in the wild-type strain, a signiﬁcant amount of 35S rRNA
precursor is still produced after 30min and even—
although to a lower extent—after 60min of rapamycin
treatment (Figure 4D). In the mutant strain expressing
Rrn3p-N-Prot.A the ratio of newly synthesized 35S
rRNA to steady state 25S rRNA levels is higher at each
time-point (up to 2-fold after 30min of TOR inactivation),
when compared to the 35S/25S rRNA ratio in a wild-type
strain (Figure 4D, graph on the right) arguing again for a
partial deregulation of rDNA transcription in the
N-mutant when TOR is inactivated. Taken together
these data indicate that (i) after TOR inactivation rDNA
transcription is reduced, but still occurs after up to 60min
of rapamycin treatment [see also (11,45)] and (ii) the re-
duction of endogenous Rrn3p levels under those condi-
tions contributes to the down-regulation of rDNA
transcription.
Lowered Rrn3p levels aﬀect Pol I–Rrn3p complex
formation, 35S pre-rRNA synthesis and cellular growth,
but do not fully mimic the response to TOR inactivation
To uncouple eﬀects of an altered Rrn3p level from other
eﬀects mediated by TOR inactivation, we generated a
strain in which the only copy of the RRN3 gene was ex-
pressed from a plasmid under the control of a doxycycline
repressible 7-fold TetO promoter (pTet7-RRN3-Prot.A)
(46). Using distinct amounts of doxycycline the expression
levels of Rrn3p could be well controlled resulting in a
strong down-regulation in the presence of 1mg/ml doxy-
cycline and a strong overexpression in the absence of the
drug (Figure 5A, lanes 1 and 4). Interestingly, the strong
decrease in Rrn3p level observed in the presence of 1mg/ml
doxycycline retarded, but did not completely inhibit
growth (Figure 5E).
Gelﬁltration of whole cell extracts derived from strains
in which Rrn3p expression was either enhanced or reduced
demonstrated again that Rrn3p levels correlated well with
the number of Pol I–Rrn3p complexes (Figure 5B). Thus,
changes in the level of Rrn3p did not signiﬁcantly alter the
elution proﬁle of the protein in gelﬁltration. This means
that a similar ratio of Rrn3p within a given population
is monomeric, associated with Pol I, or part of a higher
molecular weight complex (compare Supplementary
Figure S3A with Figure 4A and Figure 5B). Apparently,
there is a cellular mechanism maintaining a ﬁxed ratio
between free and complexed Rrn3p.
Next, we wanted to see how rRNA synthesis correlates
with pTet7-controlled Rrn3p expression-levels. pTet7-
RRN3-Prot.A cells were cultured with diﬀerent amounts
of doxycycline and were pulse labelled for 15min with
3H
uracil to monitor rRNA synthesis. We found a signiﬁcant
reduction of newly synthesized rRNA with increasing
doxycycline concentrations (Figure 5C). The amount
of nascent rRNA levels detected in pulse labelling
experiments depends on the one hand on the synthesis
of (pre-)rRNA due to Pol I dependent transcription
and/or on the other hand, on their turnover due to deg-
radation or productive processing events. Amounts of
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doxycycline dependent Rrn3p-reduction. This is reﬂected
in a constant quotient of newly synthesized 35S/27S
rRNA (Figure 5C). Since processing defects generally
lead to the distortion of the precursor rRNA ratios, we
conclude that in this experiment Pol I transcription, but
not rRNA processing is aﬀected. We further investigated
the association of the Pol I subunit A43 with the
promoter, 18S and 25S region of the rDNA in ChIP ex-
periments in dependency of Rrn3p expression (Figure 5E).
Doxycycline-dependent reduction of Rrn3p levels
correlated well with a decrease in rDNA-associated Pol
I. Taken together, our data demonstrate a correlation
between Rrn3p levels, the formation of Rrn3p–Pol I
Figure 5. Reduction of Rrn3p-levels decreases rRNA production but does not phenocopy growth-inhibition and the loss of nascent rRNAs upon
TOR inactivation. (A) Yeast strain pTet7-RRN3-Prot.A (TOY 667), expressing Rrn3p under the control of a doxycycline sensitive 7-fold
TetO-promoter was grown in YPAD at 30 C to early log phase, before cells were split and further cultured in the absence or presence of 0.1,
0.5 and 1mg/ml doxycycline (Dox), respectively. After 17h, 50ml of the cultures were collected and lysed and same amounts of WCE (30mg) were
analysed by western blotting, using an antibody directed against the Prot.A-tag of the Rrn3p. (B) Overexpression of Rrn3p results in more Pol I–
Rrn3p complexes. Yeast strain pTet7-RRN3-Prot.A was grown in YPAD at 30 C without or in the presence of 1mg/ml doxycycline to log-phase.
After lysis, same amounts of WCE (900mg) were separated on a Superose-6 column and further analysed as described in Figure 4A. Western blots
were developed with anti-A135-antibodies which recognize at the same time also Rrn3p-Prot.A through its Prot.A-tag. Note that about equal
amounts of Pol I in both strains were detected. The gel ﬁltration fractions in which Rrn3p co-migrates with Pol I are labelled in red. (C) Reduction
of Rrn3p-levels decreases rRNA synthesis. Five millilitres aliquots of strain pTet7-RRN3-Prot.A growing in the presence of various doxycycline
concentrations were pulse labelled for 15min with 20mCi of [5, 6-
3H] uracil. Twenty percent of the isolated RNA were separated by denaturing gel
electrophoresis and blotted onto a nylon membrane.
3H-labelled rRNAs were visualized using the BAS 1000 imaging system and quantiﬁed with the
Image Gauge software. The graph on the bottom represents the 35S/27S nascent rRNA ratio determined in two separate experiments. The ratio in
the 0mg/ml Dox sample was arbitrarily set to 100. (D) Reduction of Rrn3p-levels upon TOR inactivation does not explain the complete shut oﬀ of
pre-rRNA synthesis. Yeast strain RRN3-Prot.A (WT) expressing a chromosomally Prot.A-tagged Rrn3p was grown in YPD at 30 C to early log
phase (t=0min). One third of the culture was withdrawn before rapamycin was added to a ﬁnal concentration of 200ng/ml and incubation was
continued for 20 and 120min, respectively (t=20, 120min). Yeast strain pTet7-RRN3-Prot.A (TOY 667) was grown in YPD in the presence of
0.2mg/ml doxycycline (Dox) at 30 C for 18h to early log phase, and treated with rapamycin as described above. From all samples cells from 50ml
were sedimentated and WCEs were prepared, from which 30mg of protein were analysed by western blotting, using an antibody directed against the
Prot.A-tag of the Rrn3p. In parallel, 5ml of the cultures were pulse labelled for 15min with 20mCi of [5, 6-
3H] uracil and total RNA was isolated.
Equal amounts of total RNAs were separated by denaturing gel electrophoresis and visualized by Ethidium bromide staining (EtBr). After transfer
onto a nylon membrane
3H-labelled rRNAs were visualized as described in the legend to Figure 5C. (E) Chromatin-IP (ChIP) experiments. Yeast
strain pTet7-RRN3-Prot.A (TOY 667) was grown in YPD at 30 C to mid-log phase in the presence of the indicated doxycycline concentrations. Cells
were crosslinked and analysed as described for Figure 4C. (F) Rrn3p expression levels do not inﬂuence kinetics of growth inhibition upon TOR
inactivation. Strain pTet7-RRN3-Prot.A was grown without or in the presence of 1mg/ml doxycycline (DOX) and compared to strain RRN3-Prot.A
(note that this is not the exact isogenic wild-type strain to pTet7-RRN3-Prot.A). The culture was diluted to an OD600 of 0.1. After 6h half of the
culture was withdrawn and rapamycin was added to a ﬁnal concentration of 200ng/ml (indicated by an arrow). The OD600 of the culture was
monitored hourly over the entire 10-h time-course of the experiment.
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In the presence of 0.2mg/ml doxycycline the Rrn3p level
in pTet7-RRN3-Prot.A cells was very similar to the Rrn3p
level in wild-type cells after 2h of rapamycin treatment
(Figure 5D, upper panel, compare lanes 3 and 4).
Strikingly, we observed large diﬀerences in the pattern
of newly synthesized (pre)-rRNA in these two conditions:
As noted before (Figure 5C), doxycyline treatment
aﬀected the diﬀerent precursors similarly, with no
evidence for defective processing (Figure 5D, compare
lane 4 with lane 1). After 20min of rapamycin treatment
Rrn3p levels did not drop signiﬁcantly, but rRNA
labelling and processing were strongly aﬀected. [Note,
that cellular uptake of uracil was only modestly aﬀected
after 20min rapamycin treatment (data not shown, and
Reiter et al., submitted)]. Accordingly, substantial
amounts of newly synthesized 35S pre-rRNA are still
detected, whereas label incorporation in matured rRNA
species was reduced in rapamycin treated cells [compare
Figure 5D, lane 4 with lane 2/3; lane 1 with lane 2/3, and
lane 4 with lane 5/6; see also (45)].
Furthermore, in contrast to the doxycycline-treated
pTet7-RRN3-Prot.A strain, rapamycin treated cultures
stopped growth shortly after addition of the drug
(Figure 5F). Rapamycin dependent growth arrest
occurred with the same kinetics [about 1h after addition
of rapamycin (arrow in Figure 5F)], no matter whether
Rrn3p was overexpressed or scarce (Figure 5F).
Therefore, the simple reduction of Rrn3p-levels and con-
sequently the decreased association of the Pol I-machinery
with rDNA do not fully explain the dramatic eﬀects on
ribosome neo-production and cellular growth upon TOR
inhibition.
DISCUSSION
Our analyses conﬁrm that in yeast the complex control of
ribosome biosynthesis occurs on several layers. One of
them is the proteasome-dependent degradation of the
transcription factor Rrn3p which contributes to the
down-regulation of transcription initiation as a conse-
quence of TOR inactivation by rapamycin. Several obser-
vations indicate that lowered cellular Rrn3p levels after
TOR inactivation are not the result of a targeted destruc-
tion [see as review (47)], but rather the combination of a
reduced RRN3 expression rate and a constitutive short
half life of the protein (48): ﬁrst, RRN3 mRNA levels
quickly decrease upon nutrient depletion. [(38,49) and
our results, not shown]. Second, both inactivation of Pol
II-dependent transcription of the RRN3 gene in Pol II
conditional mutant and inhibition of RRN3 mRNA trans-
lation by cycloheximide reduce Rrn3p protein levels with
similar kinetics as TOR inactivation, thus, TOR inactiva-
tion aﬀects endogenous Rrn3p levels very likely at the
stage of or prior to protein production.
Ubiquitylation of Rrn3p seems to be an evolutionary
conserved feature since this modiﬁcation has recently been
reported for the mammalian homologue, TIF-IA (50).
However, in contrast to the endogenous yeast Rrn3p,
TOR-inactivation does not lead to reduced levels of
ectopically co-expressed TIF-IA in the mammalian
system (12). Thus, it appears that—although human
TIF-IA/Rrn3p substitutes the yeast homologue for
growth (51)—their activities may be diﬀerently regulated.
It is conceivable that the requirements to respond to
incoming signals diﬀer between a rapidly dividing yeast
cell and higher eukaryotic cells which have more time to
adjust to environmental situations.
Nomura and co-workers (11,40) reported that the TOR
pathway regulates Rrn3p-dependent recruitment of Pol I
to the rDNA. Using ChIP assays and EM Miller
spreading technology they calculated that inhibition of
the TOR pathway reduces the Pol I-coverage on the
rDNA gene to about 40–50% of the normal levels (40) .
In addition, they observed that the amount of Pol I
associated with Rrn3p was reduced by a factor of about
three after TOR inactivation by rapamycin (11). Our data
suggest that decreasing cellular Rrn3p levels after TOR
inactivation is one important cellular mechanism to
reduce the amount of Pol I–Rrn3p complexes. On the
other hand, in cells expressing a stabilized Rrn3p variant
we still observed some reduction in the level of Pol I–
Rrn3p complexes after nutrient depletion indicating that
Rrn3p association with Pol I can also be regulated by
other means. The kinase Tor1p was reported to be
associated with the rDNA promoter in exponentially
growing cells, whereas it shuttles to the cytoplasm upon
TOR inactivation (52). Thus, it is possible that nuclear
Tor1p directly modulates the formation and dissociation
of the Pol I–Rrn3p complex.
Experiments using a non-dissociable Pol I–Rrn3p fusion
protein (CARA for Constitutive Association of Rrn3 and
A43) are in general agreement with our conclusions (25).
The CARA strain mimics an active non-dissociable Pol I–
Rrn3p complex, which is resistant to rapamycin treatment.
Similar to the N mutant analysed in this study this strain
shows an attenuation of the rapamycin-dependent repres-
sion of transcription. However, the retention of Pol I at the
rDNA upon rapamycin treatment is signiﬁcantly higher in
the CARA strain than in the N mutant strain upon
nutrient starvation [compare Figure 4C in this study with
Figure 2B in (25)]. This is consistent with the interpret-
ation, that in the CARA strain, both, the decrease in
Rrn3p protein levels, and the Rrn3p-A43 dissociation are
prevented. On the other hand, also in CARA expressing
cells overall rRNA synthesis is substantially reduced upon
rapamycin treatment (Figure 4D in (25)). This indicates the
existence of other mechanisms regulating rRNA produc-
tion independent of the formation of the Pol I–Rrn3p
complex also in this experimental system.
If we adjust Rrn3p levels to values substantially below
the reduced amounts of Rrn3p observed upon TOR in-
activation by rapamycin, we ﬁnd a signiﬁcant reduction in
rRNA synthesis. In contrast to TOR inactivation,
however, mature rRNAs are still produced even if
amounts of initiation competent Pol I–Rrn3p complexes
are minimal. We conclude that nutrient dependent regu-
lation of cellular Rrn3p levels alters rDNA transcription
on the level of the (re-) initiation rate (11,42) but does not
fully account for the TOR-dependent shut-down of
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of ribosome maturation after TOR inactivation, as
indicated by the relative accumulation of the 35S rRNA
precursor (Figures 4D and 5D) and the re-localization of
certain ribosome biogenesis factors (53,54), could explain
these obvious diﬀerences.
In conclusion, our work investigating the eﬀects of
Rrn3p level alterations has revealed that the endogenous
Rrn3p level is a determinant for the formation of initiation
competent Pol I–Rrn3p complexes, inﬂuencing the
(re-)initiation rate at rRNA genes. Rrn3p levels can thus
directly inﬂuence Pol I transcription, which may be im-
portant for long-term adjustment of ribosome synthesis.
TOR inactivation also reduces Rrn3p levels but we
provide clear evidence that this reduction cannot explain
the dramatic decrease in mature rRNA production
(Figure 5D). Accordingly, artiﬁcial down-regulation of
Rrn3p slows down but does not inhibit cell growth,
whereas TOR inactivation results in immediate growth
arrest. This all supports the idea, that under certain
physiological situations down-regulation of rRNA pro-
duction can be uncoupled from eﬃcient Pol I initiation
complex formation. Therefore, a main target of TOR in-
activation in yeast to quickly adjust ribosome biosynthesis
to changes in environmental conditions is likely down-
stream of transcription initiation (see also Reiter et al.,
submitted).
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